Pernal, M. (2026) “Use of GLP-1 Analogues in Patients with Schizophrenia and Other Neuropsychiatric Disorders: A Literature Review”, Quality in Sport, 54, p. 70410. doi: 10.12775/QS.2026.54.70410.